If the level of CgA was significantly increased, accompanied by PSA > 20 ng/mL, Gleason score ≥8, clinical stage of T3-T4 or regional lymph node metastasis, it was considered as high-risk prostate cancer and highly suspected as neuroendocrine prostate cancer. The gene discussed is CGA; the disease is prostate cancer.